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Abstract—Neurogenesis in the subgranular zone (SGZ) of the adult hippocampus can be stimulated by a variety of
means, including via exposure of experimental animals to an enriched environment that provides additional sen-
sory, social, and motor stimulation. Tangible health and cognitive benefits accrue in enriched animals, including
the amelioration of signs modelling psychiatric, neurological and neurodegenerative conditions that affect
humans, which may in part be due to enhanced production of neurons. A key factor in the neuronal response
to enrichment is the release of brain-derived neurotrophic factor (BDNF) and the activation of the Mitogen-
Activated Protein Kinase (MAPK) cascade, which can lead to the stimulation of neurogenesis. Mitogen- and
Stress-Activated protein Kinase 1 (MSK1) is a nuclear enzyme downstream of BDNF and MAPK that regulates
transcription. MSK1 has previously been implicated in both basal and stimulated neurogenesis on the basis of
studies with mice lacking MSK1 protein. In the present study, using mice in which only the kinase activity of
MSK1 is lacking, we show that the rate of cellular proliferation in the SGZ (Ki-67 staining) is unaffected by the
MSK1 kinase-dead (KD) mutation, and no different from controls levels after five weeks of enrichment. However,
compared to wild-type mice, the number of doublecortin (DCX)-positive cells was greater in both standard-housed
and enriched MSK1 KD mice. These observations suggest that, while MSK1 does not influence the basal rate of
proliferation of neuronal precursors, MSK1 negatively regulates the number of cells destined to become neurons,
potentially as a homeostatic control on the number of new neurons integrating into the dentate gyrus.  2020 The
Author(s). Published by Elsevier Ltd on behalf of IBRO. This is an open access article under theCCBY-NC-ND license (http://crea-
tivecommons.org/licenses/by-nc-nd/4.0/).
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Progenitor cells located in the subgranular zone (SGZ) of
the hippocampal dentate gyrus (DG) contribute to the
diverse roles the hippocampus plays through the
integration of the newly differentiated cells into the
hippocampal circuitry and the formation of new
functional neuronal networks with other brain areas
(Aimone et al., 2011; Cameron and Glover, 2015;
Vicidomini et al., 2020). Several factors such as terato-
gens, injury, environmental enrichment, exercise, and
stress have been shown to impact on the hippocampal
neurogenic rate (Shors et al., 2012; Song et al., 2012;https://doi.org/10.1016/j.neuroscience.2020.11.017
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228Cameron and Glover, 2015; Opendak et al., 2016). This
suggests that the hippocampus is tuned to adjust its neu-
rogenic capability to prevailing synaptic and environmen-
tal influences in order to maintain its functionality. These
observations have provoked investigations into the mech-
anisms that convert extrinsic influences into the genomic
changes that underpin the regulation of neurogenesis
(Poiana et al., 2020).
Prominent among the regulators of neurogenesis in
response to exercise and environmental enrichment are
the neurotrophins, and in particular brain-derived
neurotrophic factor (BDNF) (Vilar and Mira, 2016;
Numakawa et al., 2018). BDNF activates the Mitogen-
Activated Protein Kinase (MAPK) pathway leading to the
activation of Extracellular Signal-Regulated Kinases
(ERK1/2), which have repeatedly been implicated in neu-
rogenesis (Chen et al., 1992; Sugino et al., 2000; Nozaki
et al., 2001; Lennmyr et al., 2002; Choi et al., 2008; Li
et al., 2010). ERK1/2 regulate transcription leading toons.org/licenses/by-nc-nd/4.0/).
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Tian et al., 2009), either by direct interaction with tran-
scription factors, or via the activation of a series of down-
stream kinase pathways including Mitogen- and Stress-
Activated protein Kinase 1 and 2 (MSK1/2) (Deak et al.,
1998; Wiggin et al., 2002; Hauge and Frodin, 2006;
Reyskens and Arthur, 2016).
MSKs are prominent regulators of gene transcription
through the phosphorylation of both CREB and histone
H3 (Deak et al., 1998; Wiggin et al., 2002; Soloaga
et al., 2003; Chwang et al., 2007; Reyskens and Arthur,
2016), and indeed, play a major role in CREB phosphory-
lation at the primary activating serine residue (S133) in
response to BDNF (Arthur et al., 2004). MSK1’s presence
in DG granule cells (Choi et al., 2012; Karelina et al.,
2012) activation by BDNF, phosphorylation of CREB
(Arthur et al., 2004; Daumas et al., 2017) and regulation
of transcription (Reyskens and Arthur, 2016; Privitera
et al., 2020) likely explain why MSK1/2 have been previ-
ously shown to regulate neurogenesis. Studies using
either single MSK1 knockouts, or double knockouts of
both MSK1 and MSK2 have shown that loss of MSKs
results in reduced numbers of BrdU-, Ki-67-, and DCX-
positive cells in the SGZ under basal conditions (Choi
et al., 2012; Karelina et al., 2012) and in response to sta-
tus epilepticus (Choi et al., 2012), environmental enrich-
ment (Karelina et al., 2012), and cerebral ischemia
(Karelina et al., 2015). These observations suggest an
important role for MSKs in basal and responsive neuroge-
nesis, and may explain the reduced volume of the granule
cell layer in MSK1/2 double knockout mice (Choi et al.,
2012).
These neurogenic deficits are associated in MSK1
knockouts with aberrant developing and mature
hippocampal neuron morphology and dendritic spine
count (Choi et al., 2012; Karelina et al., 2012, 2015),
and impairments in various tests of learning and memory,
including the Barnes maze, novel object recognition
(Karelina et al., 2012), fear conditioning and the Morris
water maze (Chwang et al., 2007), implicating MSK1 in
a range of crucial cellular and cognitive functions.
However, a subsequent mutant of MSK1, in which
the kinase domain of the enzyme was selectively
targeted leading to an extant, but kinase dead (KD)
enzyme, revealed a different phenotype in terms of
increased basal hippocampal CA1 spine density
(Corrêa et al., 2012; Privitera et al., 2020), and the
absence of cognitive impairment in tests of spatial work-
ing memory (spontaneous alternation) and spatial refer-
ence memory (Morris water maze) (Daumas et al.,
2017; Privitera et al., 2020). This discrepancy in the
phenotypes of knockout vs kinase-dead MSK1 mutants
may reflect a structural role for MSK1 in forming a tran-
scriptional regulation complex with ERK1/2 and the glu-
cocorticoid receptor (Gutierrez-Mecinas et al., 2011).
The absence of MSK1 protein in the single MSK1 or
double MSK1/2 knockouts could therefore lead to dys-
regulation of this complex and impaired transcriptional
regulation, independent of MSK10s kinase-dependent
influence on the genome, cellular morphology and
cognition.Accordingly, because of the dual structural and kinase
functions of MSK1, the role that MSK1 plays in
neurogenesis is unclear. To address this, we have
examined neurogenesis in the hippocampal SGZ in
MSK1 kinase-dead (MSK1 KD) and wild-type (WT) mice
under conditions of standard housing and in response to
5 weeks of environmental enrichment. We show that the
number of Ki-67-positive cells is unaffected by either
enrichment or the loss of MSK1 kinase activity,
suggesting both the absence of active cellular division at
this time point, and the lack of involvement of MSK1
kinase activity in neuronal precursor proliferation.
Intriguingly, greater numbers of DCX-positive cells were
seen in the MSK1 KD mutant mice under both basal
and enriched conditions. These observations suggest
that the kinase activity of MSK1 negatively regulates the
maturation of neuronal precursors, and is therefore
necessary to maintain the homeostatic balance of SGZ
neurogenesis in the integration of new neurons into the
hippocampal DG.EXPERIMENTAL PROCEDURES
Wild-type and MSK1 Kinase-Dead mice
The experimental animals were used according to the
guidelines of the United Kingdom Animals (Scientific
Procedures) Act 1986 and the University of Warwick’s
ethical review procedures. The MSK1 kinase-dead
(MSK1 KD) mouse has been described previously
(Corrêa et al., 2012; Daumas et al., 2017; Privitera
et al., 2020). All the mice used in this study were on a
C57-Bl/6J genetic background. WT and homozygous
MSK1 KD mutant mice were maintained as separate lines
that were initially derived from founder homozygous and
WT breeders from heterozygote crosses. To avoid
genetic divergence, backcrossing occurred when the
founder mice reached the end of their reproductive life
cycle (typically three litters) (Privitera et al., 2020). The
MSK1 KD mutant mice were healthy, viable, fertile and
had a similar age-span to that of WT mice, from which
they were indistinguishable by appearance. They were
neurologically intact, and their sensorimotor behaviour
was identical to that of WT mice (Daumas et al., 2017;
Privitera et al., 2020). Confirmation of genotype was per-
formed routinely by PCR using the primers 5ʹ-CGGCCA
TGTGGTGCTGACAGC-3ʹ and 5ʹ-GGGTCAGAGGCCTG
CACTAGG-3ʹ which resulted in 378 and 529 bp products
for both the wild-type and targeted alleles, respectively.
Mice were maintained under a 12/12 light dark cycle
(lights on at 7.00 am) in a facility kept at 20–24 C and
were given ad libitum access to standard mouse chow
and water.Housing condition
At 4 weeks of age (one week after weaning) male WT and
MSK1 KD mutant mice either remained in standard
housing (SH; Tecniplast 1284L; 365  207  140 mm;
530 cm2 floor area; 2–3 mice per cage, with bedding
material and a cardboard tube), or were transferred to
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480  375  210 mm; 1500 cm2 floor area). Enriched
cages housed 4–5 mice per cage, and cages contained
bedding material, a cardboard tube, one running wheel,
a number of plastic toys (e.g. tunnels, platforms, see-
saws), and a metal ladder. As a further enrichment and
to provide novelty, the toys were moved around twice
per week and new toys introduced once per week when
cages were cleaned (Privitera et al., 2020). Mice
remained in either the EE or SH for a further 5 weeks until
the brains were processed for immunohistochemistry.
Twenty mice were used in this study: 5 WT SH mice, 4
WT EE mice, 6 MSK1 KD SH mice, and 5 MSK1 KD
EE mice.Immunohistochemistry
The mice were killed by cervical dislocation and the brains
were rapidly removed and placed in 4%
paraformaldehyde in 0.1 M phosphate buffer (PB) for
24 h at 4 C. The brains were subsequently
cryoprotected by immersion in 30% buffered sucrose
solution in 0.1 M PB at 4 C until they equilibrated. Cryo-
protected left hemispheres (n = 20) were sectioned at
40 mm in the sagittal plane. Endogenous peroxidase
activity was reduced by pre-incubating the sections in
an endogenous peroxidase inhibitor solution (1.6% of
30% H2O2, 49.2% methanol, 49.2% 0.1 M PB) for
30 min. Unspecific binding sites in the sections were
blocked by pre-incubating in blocking buffer (2% bovine
serum albumin and 0.25% Triton X-100 in 0.1 M PB).
Thereafter, every fourth section from the same animal
was immunolabelled with either anti-Ki-67 (for
immunolabelling proliferative cells) (1:1000 rabbit anti-
Ki-67; Abcam ab15580) or anti-doublecortin (DCX) (for
immunolabelling newly formed cells) (1:300 rabbit anti-
DCX; Abcam ab18723) for 48 h at 4 C under gentle
agitation. The sections were then incubated in a
secondary antibody solution (1:1000 goat anti-rabbit IgG
(biotinylated); Abcam ab6720) for 2 h at room
temperature. This was followed by incubation for 1 h in
an avidin–biotin solution (1:125; Vector Labs). Sections
were placed in a solution of 0.05% diaminobenzidine
(DAB) in 0.1 M PB for 5 min, followed by the addition of
3.3 lL of 30% hydrogen peroxide per 1 mL of DAB
solution for 2 min for section developments. Finally,
sections were mounted on 0.5% gelatin-coated glass
slides, dried overnight, dehydrated in alcohol series,
cleared in xylene and coverslipped with DPX. Non-
specific immunolabelling in sections was ruled out by
omitting either the primary or the secondary antibody,
no staining was observed in both cases (results not
shown).Quantification of Ki-67- and DCX-positive cells in the
DG
Positively immunolabelled Ki-67- and DCX-positive cells
(identified as those having dark nuclear staining) in the
SGZ were counted along the whole rostro-caudal length
of the suprapyramidal blade of the DG at 40
magnification using an Axiovision light microscope. Cellswere counted if they lay within or touched the SGZ. For
all the experimental groups, between 3 and 7 (typically
5) sections/brain/immunostain (i.e. between 21 and 33
sections per each of the four experimental groups) were
analysed in the medio-lateral plane. To determine the
distribution of positive cells in the suprapyramidal blade
in each section, the rostro-caudal length of the
suprapyramidal blade was photographed with a camera
attached to an Axiovision light microscope at 5
magnification. From each photograph with its inscribed
scale bar (i.e. for scale setting), the length of the blade
was then carefully measured using ImageJ 1.47v
software (NIH, USA). The distribution of positive cells in
each section was calculated by dividing the total number
of Ki-67- or DCX-positive cells counted by the measured
length of the corresponding suprapyramidal blade of the
DG. The data points for each of these sections, and
when aggregated on a per animal basis, are provided in
Fig. 1 with respect to stain and experimental group.
Throughout the preparation of the tissue, the counting of
cells and analyses, the experimenter was completely
blinded as to which of the four experimental groups
each animal belonged.Statistical analysis
Once the cell counting was complete for all sections, the
data were assigned to four experimental groups, at which
point the housing condition and genotype of each of the
four groups were revealed. Statistical analysis was
performed using SPSS 27. Data were subject to tests of
normality (Shapiro–Wilk test) and equivalence of
variance (Levene’s test). For normally-distributed data
displaying equivalent variances, a two-way ANOVA,
utilising a General Linear Model (Fixed effects), was
employed, with genotype and housing condition as the
two between-group factors. Post-hoc comparisons of the
Simple Main Effects were conducted when appropriate.
When necessary the data were analysed with non-
parametric statistics (Kruskal–Wallis and Mann–Whitney
U tests). Alpha was 0.05 for every analysis. Data points
presented in Fig. 1 represent the counts from individual
sections for each stain and experimental group, or the
aggregate data from individual animals, with measures
of the median, and 10–90 % and 25–75 % range
indicated. Statistical significance was assumed when
p< 0.05.RESULTS
There were no observable differences in the general
morphology or the neuronal distribution patterns in the
brains of all the experimental mice (genotypes and
housing) as described previously (Corrêa et al., 2012),
and specifically so in the DG of the hippocampus as the
Ki-67 and DCX immunopositive cells were present in the
distinct proliferative region i.e. SGZ of the DG (Fig. 1A,
B). In addition, the suprapyramidal and infrapyramidal
blades of the DG were present in all the mice assessed,
with distinct boundaries in both immunostains used.
There was no observable difference in their patterns
(Fig. 1A, B).
Fig. 1. MSK1 negatively regulates hippocampal neurogenesis. Top photomicrographs represent the dentate gyri of the hippocampi for (A) DCX and
(B) Ki-67 immunostaining. The photographs of higher magnification show (A) the newly formed neurons immunolabelled with anti-DCX and (B) the
proliferative cells immunolabelled with anti-Ki-67 within the subgranular layer of the suprapyramidal blade. Significant differences were observed
between genotypes for the number of DCX-positive cells when assessed on a per histological section basis (C) or when assessed on a per animal
basis (D), but not for the number of Ki-67-positive cells in either individual histological sections (E) or when aggregated on a per animal basis (F).
Only a trend (p= 0.077) was observed for the effects of enrichment on DCX expression in C. Individual data points presented in (C, E) represent
the number of DCX- or Ki-67-positive cells per histological section (between 21 and 33 sections) and in (D, F) from 4 to 6 animals per group,
normalised to the length of dentate gyrus examined. The box represents 25–75 % of the range; the whiskers represent the 10–90% range, and the
median is given by the horizontal bar.
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suprapyramidal blade of the DG in the WT or MSK1 KD
mice housed in SH or EE was quantified. The data were
analysed in two ways: on a per histological section
basis (n= 21–33 across each of the four groups), and,
noting concerns regarding the non-independent nature
of the data points in such an approach (Aarts et al.,
2014), on a per animal basis (n= 4–6). The results of
both approaches yielded identical conclusions.
In the analysis of DCX+ cells in individual sections
(Fig. 1C), the data across the four groups were normally
distributed (Shapiro Wilk), but a test of equality of
variance (Levene) indicated unequal variance across the
four groups (F(3,105) = 4.216, p= 0.007), necessitating
the use of the non-parametric Kruskal-Wallis (KW) test.
The KW analysis showed a significant difference in the
number of DCX+ cells between groups (H(3) = 19.77,
p= 0.000). In order to investigate the effect of the two
between-group variables, genotype and housing
conditions, on DCX expression, the Mann–Whitney
(MW) U test was employed. There was a significant
effect of genotype (U= 790.0, p= 0.000, r= 0.39)
where the MSK1 KD had a greater number of DCX+
cells, with a trend towards significance for housing
conditions with a tendency for the enriched groups to
have more DCX+ cells (U= 1180.0, p= 0.077,
r= 0.17). A further MW analysis on the individual
groups showed that, while there was no significant
effect due to housing within the same genotype (WT SH
vs. WT EE; U= 229.0, p= 0.257, r= 0.16 and MSK1
KD SH vs. MSK1 KD EE; U= 346.0, p= 0.093,
r= 0.21), there was a significant difference between
genotypes in each housing condition, with the MSK1 KD
mice having more DCX+ cells than their comparably
housed WT counterparts (WT SH vs MSK1 KD SH;
U= 239.0, p= 0.002, r= 0.40 and WT EE vs. MSK1
KD EE; U= 159.0, p= 0.006, r= 0.39). The greater
numbers of DCX-positive cells in both SH and EE MSK1
KD mice persisted when the data was aggregated on a
per animal basis, in which the groups did not deviate
from a normal distribution, and showed equivalent
variance (Two-way ANOVA; WT vs. MSK1 KD:
F(1,16) = 5.77, p= 0.029; Fig. 1D). These data suggest
that the kinase activity of MSK1 exerts an inhibitory
regulatory influence on neurogenesis, potentially to
avoid the over-population of the DG with new neurons.
For the Ki-67 analysis of individual histological
sections (Fig. 1E), the variance in the data was
equivalent across groups (Levene test; F(3,111) = 0.435,
p= 0.729), but one group (MSK1 KD SH) failed the
Shapiro–Wilk test for normality (W(32) = 0.920,
p= 0.021). Accordingly, the data were analysed with
non-parametric tests. The number of Ki-67-positive cells
was not significantly different across the four groups
(KS; F(3) = 4.575, p= 0.206). There were no
differences between the WT and MSK1 KD mice (MW;
U= 1633.0, p= 0.955, r= 0.005), and no significant
difference in the distribution of Ki-67+ cells between the
two housing conditions (MW; U= 1342.0, p= 0.087,
r= 0.16). When the data were aggregated on a per
animal basis (Fig. 1F), where normality and equivalenceof variance of data were satisfied, no differences in Ki-
67 expression across the four groups were observed
(Two-way ANOVA; Genotype effect: F(1,16) = 0.076,
p= 0.786; Housing effect: F(1,16) = 1.144, p= 0.301;
Genotype  Housing interaction: F(1,16) = 0.623,
p= 0.441). These data suggest that at this time point,
after 5 weeks of enrichment, active proliferation of cells
in the DG is not observed, but equally that the kinase
activity of MSK1 is not required for the maintenance of
neurogenic potential.DISCUSSION
The factors influencing the experience- and exercise-
dependent stimulation of neurogenesis have been
intensively pursued given the potential to harness this
knowledge for therapeutic benefit in conditions
associated with cognitive decline such as Alzheimer’s
disease (Chohan, 2020; Mihardja et al., 2020). One
potential approach is to develop exercise- or
environment-mimetic drugs that activate the pathways
recruited by enrichment for clinical benefits in patients
(Guerrieri et al., 2017; Shepherd et al., 2018). Of note,
BDNF-based approaches, such as the small molecule
BDNF mimetic 7,8-dihydroxyflavone, have been shown
to stimulate neurogenesis and reverse cellular and cogni-
tive impairments in animal models of traumatic brain injury
(Wurzelmann et al., 2017), psychiatric conditions
(Gudasheva et al., 2019), neurodevelopmental disorders
(Du and Hill, 2015), and neurodegeneration (Kazim and
Iqbal, 2016; Choi et al., 2018). In humans, the potential
benefits of exercise and physical activity may be medi-
ated through an increase in BDNF (Kazim and Iqbal,
2016). It is thus against this backdrop that the importance
of BDNF-dependent signaling in the regulation of neuro-
genesis is appreciated.
Key to BDNF signaling is MSK1, a nuclear kinase
downstream of the BDNF TrkB receptor and MAPK
cascade, that regulates transcription through chromatin
remodeling and the phosphorylation of CREB
(Reyskens and Arthur, 2016). Using a kinase-dead
mutant of MSK1, we have previously shown that the
kinase activity of MSK1 is necessary for the transcrip-
tional regulation of Arc/Arg3.1 (Hunter et al., 2017), sup-
port of basal synaptic transmission (Daumas et al.,
2017), homeostatic synaptic plasticity, the experience-
dependent enhancement of quantal synaptic transmission
and the expansion of the dynamic range of synapses,
cognitive flexibility and the persistence of memory, and
the genomic downscaling of key plasticity-related proteins
such as EGR1 and Arc/Arg3.1 (Corrêa et al., 2012;
Privitera et al., 2020). MSK1 likely plays a role in sensing
prevailing experience-driven neuronal activity, in
response to the associated activity-dependent release of
BDNF, and orchestrates a genomic program designed
to allow neurons to respond to and adapt to a dynamic
environment. It is thus not surprising that MSK1 has been
implicated in basal and responsive neurogenesis, where
its deletion results in impaired neurogenesis as assessed
by reduced BrdU, DCX and Ki-67 labelling in the
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2015).
Specifically addressing the role the kinase function of
MSK1 plays in neurogenesis using a kinase-dead MSK1
mutant mice, we have made observations at odds with
previous reports in MSK knockout mice. We show that
the neurogenic potential of the SGZ, as assessed
through Ki-67, a marker for cellular proliferation, is not
affected by the loss of MSK10s kinase activity under
basal standard housing conditions. While this suggests
that MSK1 is not involved in determining the potential
for subsequent neuronal differentiation, further analysis
is required with additional markers of neurogenesis (e.g.
Nestin) to establish the identity of these proliferating
cells and the relative role of MSK. Indeed, such further
analysis may determine if the MSK2 isoform was able to
compensate for the lack of MSK1 kinase activity. That
enrichment did not provoke an increase in Ki-67-
reported cellular division may indicate that at this late
time point (5 weeks of enrichment) any initial surge in
cellular proliferation has occurred, and proliferation has
returned to baseline levels. That an earlier surge in
proliferation may have occurred in response to
enrichment is suggested by the tendency towards
increased number of DCX-positive cells in the SGZ of
enriched mice. While there are ample precedents for the
stimulation of neurogenesis by enrichment
(Kempermann et al., 1997; Kempermann, 2019), this
was not fully captured in the present study. This is poten-
tially due to under-powering of the experimental groups,
the single time point and age at which the analysis was
conducted, and perhaps due to relatively enriched stan-
dard housing conditions, with litter mates, nesting material
and cardboard tube, which may have contributed to the
stimulation of neurogenesis and thus reducing differences
between housing conditions.
Intriguingly, however, the number of DCX-positive
cells were significantly greater in MSK1 KD mice raised
under both standard and enriched conditions. These
observations suggest that the kinase activity of MSK1
negatively regulates the extent of neurogenesis, and
prevents an excess of newly-formed neurons. Whether
this regulation of neurogenesis occurs by limiting
production of new neurons, and/or limiting their
persistence, remains to be addressed, but such over-
production may have negative impacts for hippocampal
function, and indeed increased numbers of neurons
have been described in neurodevelopmental conditions
such as the autism spectrum disorders (ASD) (Fan and
Pang, 2017). MSK1, also negatively regulates dendritic
spine density in CA1 pyramidal neurons (Corrêa et al.,
2012; Privitera et al., 2020), an overabundance of which
has also been implicated in ASD (Nakai et al., 2018).
MSK1 may thus exert an important homeostatic function
in regulating the number of neurons, the synaptic contacts
between them, and the networks in which they participate.
In summary, the present observations, of enhanced
neurogenesis in mice lacking the kinase activity of
MSK1, compared to previous reports of reduced
neurogenesis in mice lacking MSK1 protein, suggest
differential roles of MSK1 as an enzyme, and as astructural component of a transcription-regulating
complex. Our observations identify MSK10s kinase
activity as an important homeostatic mechanism in the
regulation of hippocampal neurogenesis. These studies,
together with previous observations in MSK1 KD mice,
suggest that MSK1 senses prevailing environmental and
synaptic influences and responds in an experience- and
activity-dependent manner to influence a genomic
program capable of allowing appropriate cellular,
synaptic and cognitive adaptations, and to maintain the
stability of neuronal networks.ACKNOWLEDGMENTS
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